Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q1

3034.TEDINET S100ROAI
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥43.4bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥170.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥40.5bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥1.9bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥1.7bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥1.9bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥10.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.8bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥1.9bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.8bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥1.0bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.0bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥999m2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥104.0bnat 2023-06-30Cons.Assets
Total assets¥101.9bnat 2023-03-31Cons.Assets
Total assets¥98.1bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥54.7bnat 2023-06-30Cons.Liabilities
Total liabilities¥53.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥49.3bnat 2023-06-30Cons.Net assets
Net assets / equity¥48.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥44.5bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥19.3bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥18.8bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥27.222023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥152.962022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.182022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio47.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio47.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥102m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥102m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥876m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2023-04-01 → 2023-06-30¥39.6bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2023-04-01 → 2023-06-30¥39.5bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥16m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2023-04-01 → 2023-06-30¥2.4bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥86m
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-06-30¥327m
—segment totalrevenue2023-04-01 → 2023-06-30¥43.5bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥43.4bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥102m
—segment totalsegment profit2023-04-01 → 2023-06-30¥2.7bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥77m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥77m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥830m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥17m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥3.5bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.4bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥60m
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥349m
—segment totalrevenue2022-04-01 → 2022-06-30¥40.6bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥40.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥77m
—segment totalsegment profit2022-04-01 → 2022-06-30¥2.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 351
ItemContextValueUnit
Valuation and translation adjustmentsPrior1YearInstant-14000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-13000000JPY
Non controlling interestsPrior1YearInstant47000000JPY
Non controlling interestsCurrentQuarterInstant45000000JPY
Net assetsPrior1YearInstant48856000000JPY
Net assetsCurrentQuarterInstant49302000000JPY
Liabilities and net assetsPrior1YearInstant101905000000JPY
Liabilities and net assetsCurrentQuarterInstant104039000000JPY
Net salesPrior1YTDDuration40550000000JPY
Net salesCurrentYTDDuration43403000000JPY
Cost of salesPrior1YTDDuration35455000000JPY
Cost of salesCurrentYTDDuration37730000000JPY
Gross profitPrior1YTDDuration5095000000JPY
Gross profitCurrentYTDDuration5673000000JPY
Selling general and administrative expensesPrior1YTDDuration3436000000JPY
Selling general and administrative expensesCurrentYTDDuration3799000000JPY
Operating incomePrior1YTDDuration1658000000JPY
Operating incomeCurrentYTDDuration1873000000JPY
House rent income noiPrior1YTDDuration10000000JPY
House rent income noiCurrentYTDDuration30000000JPY
Commission fee noiPrior1YTDDuration28000000JPY
Commission fee noiCurrentYTDDuration48000000JPY
Subsidy income noiPrior1YTDDuration0JPY
Subsidy income noiCurrentYTDDuration2000000JPY
Guarantee commission received noiPrior1YTDDuration14000000JPY
Guarantee commission received noiCurrentYTDDuration14000000JPY
Subsidy income noi bountyPrior1YTDDuration71000000JPY
Subsidy income noi bountyCurrentYTDDuration9000000JPY
Other noiPrior1YTDDuration15000000JPY
Other noiCurrentYTDDuration23000000JPY
Non operating incomePrior1YTDDuration141000000JPY
Non operating incomeCurrentYTDDuration128000000JPY
Interest expenses noePrior1YTDDuration20000000JPY
Interest expenses noeCurrentYTDDuration25000000JPY
Rent expenses noePrior1YTDDuration－JPY
Rent expenses noeCurrentYTDDuration17000000JPY
Other noePrior1YTDDuration19000000JPY
Other noeCurrentYTDDuration19000000JPY
Non operating expensesPrior1YTDDuration39000000JPY
Non operating expensesCurrentYTDDuration62000000JPY
Ordinary incomePrior1YTDDuration1760000000JPY
Ordinary incomeCurrentYTDDuration1940000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration0JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration0JPY
Extraordinary incomeCurrentYTDDuration0JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration5000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration12000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration－JPY
Loss on sales of noncurrent assets elCurrentYTDDuration3000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass